Bifogade filer
Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. SEE ALSO THE SECTION ”IMPORTANT INFORMATION” BELOW IN THIS DOCUMENT.
The Swedish language prospectus regarding the rights issue in Vimian Group AB (publ) ("Vimian") of approximately SEK 1,633 million (the "Rights Issue"), as resolved by the Board of Directors on 8 March 2024 based on the authorisation from the Annual General Meeting on 2 June 2023, has today, on 18 March 2024, been approved by the Swedish Financial Supervisory Authority.
The subscription period runs between 19 March 2024 and 3 April 2024. The prospectus and application forms for subscription without preferential rights can be obtained from Vimian and Carnegie and are available on Vimian's website www.vimian.com and on Carnegie's website www.carnegie.se. The prospectus will also be made available on the Swedish Financial Supervisory Authority’s website, www.fi.se.
Advisors
Carnegie Investment Bank AB (publ) and DNB Markets, a part of DNB Bank ASA, Sweden Branch, are Joint Global Coordinators and Joint Bookrunners and Advokatfirman Vinge KB is legal advisor to Vimian in connection with the Rights Issue.